South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Its Reg S/144A deal, led by Citigroup, Crédit Agricole, ING and MUFG as global coordinators and physical bookrunners, is a ...
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market.
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price ...
Novo Nordisk and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices ...
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to ...
Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...
The drugs are listed in alphabetical order. Aprepitant oral suspension: Merck reported a shortage of Emend, its aprepitant oral suspension. Merck did not provide a reason for the shortage. The ...
Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear — the eggs used to ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback